A randomized, controlled clinical trial to evaluate the immunogenicity of a PreS/S hepatitis B vaccine Sci-B-Vac™, as compared to Engerix B®, among vaccine naïve and vaccine non-responder dialysis patients
Crossref DOI link: https://doi.org/10.1007/s10157-017-1416-7
Published Online: 2017-04-29
Published Print: 2018-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Elhanan, E.
Boaz, M.
Schwartz, I.
Schwartz, D.
Chernin, G.
Soetendorp, H.
Gal Oz, A
Agbaria, A.
Weinstein, T. http://orcid.org/0000-0003-3584-4812
License valid from 2017-04-29